MENU
Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 01, 2026
TickeronGET DAILY SIGNALS
Albemarle (ALB) vs SQM: Lithium Producers Side by Side

Albemarle (ALB) vs SQM: Lithium Producers Side by Side

Key Takeaways

  • Both ALB and SQM are lithium-focused producers whose earnings have surged in recent quarters on higher lithium prices and volumes.
  • Tickeron AI Verdict: ALB is the current favorite, reflecting stronger relative momentum, a more diversified asset base, and a rapidly improved balance sheet.
  • Albemarle has demonstrated greater share-price momentum over the past year, while SQM offers broader non-lithium exposure through iodine and specialty plant nutrition.
  • SQM carries a higher dividend yield and a lower-cost brine resource, but its results are more concentrated in Chile, adding regulatory and geopolitical sensitivity.
  • Investors can track ALB Major News and ALB Today's Price Move, along with SQM Major News and SQM Today's Price Move, for ongoing updates on these tickers.
  • For a broader view of automated market strategies, explore Trending AI Robots.

Setting the Stage

Albemarle Corporation (ALB) and Sociedad Química y Minera de Chile S.A. (SQM) stand out as two of the leading lithium producers worldwide. They supply a key material for electric vehicle batteries and large-scale energy storage systems. Both have seen benefits from the rebound in lithium prices following an extended slump, though their business models, geographic footprints, and risk exposures set them apart. This comparison matters for investors assessing how these companies stack up in the specialty chemicals and battery materials sector.

Albemarle's Recent Results

Headquartered in Charlotte, North Carolina, Albemarle operates as the largest lithium producer globally, with hard-rock mines in Australia, brine assets in Chile, and processing plants in Asia and the United States. It also maintains a Specialties segment centered on bromine and related chemicals. The company reported first-quarter net sales up roughly 33% year over year, while adjusted EBITDA more than doubled in the latest quarter thanks to better lithium pricing and higher volumes. Management has pointed to global lithium demand growth of about 45% year over year through mid-2026, supported by stationary storage and recovering EV demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Balance-sheet improvements, including debt repayments that cut leverage and interest expenses, have added support, along with ongoing cost and productivity efforts.

SQM's Recent Results

Sociedad Química y Minera de Chile runs operations in lithium, iodine, specialty plant nutrition, and solar salts. Its Salar de Atacama site ranks among the lowest-cost lithium resources, and the company also holds an interest in the Mt. Holland project in Australia. First-quarter revenue came in near US$1.76 billion, with adjusted EBITDA of roughly US$837 million and margins close to 48%. Lithium volumes rose about 25% year over year, prompting management to lift full-year volume guidance amid steady demand. Iodine pricing at record levels has provided an additional boost. That said, the stock has pulled back recently after a strong advance, with attention turning to Chilean regulatory and royalty matters. The diversified commodity mix and competitive dividend yield offer some buffer against lithium-specific swings.

Direct Comparison

Both companies ride the lithium growth wave, yet their structures differ. Albemarle brings greater geographic and product diversification, combining lithium with its bromine specialties business and Australian joint-venture exposure. SQM relies more heavily on its low-cost Chilean brine operation while gaining stability from iodine and plant nutrition. Albemarle’s recent debt reduction has enhanced financial flexibility, whereas SQM’s non-lithium segments support earnings consistency and a higher yield. Momentum favors Albemarle over the trailing year, while SQM has given back some gains, leaving a mixed technical outlook. Risk factors also vary: SQM faces concentrated exposure to Chilean policy shifts, and Albemarle navigates operations across multiple regions.

Tickeron AI Assessment

Considering trend consistency, relative momentum, balance-sheet progress, and diversification, Tickeron’s AI points toward ALB as the stronger choice in the present setting. Albemarle’s firmer trailing-year performance, lower leverage, and wider asset base deliver a steadier signal, while SQM’s recent retracement and Chile-centric risks add a layer of near-term uncertainty. This view remains probabilistic and could adjust with shifts in lithium prices or new earnings data.

AI Tools in Practice

When evaluating names like these, I find it helpful to review automated strategies through Tickeron’s Trending AI Robots. The platform highlights a selection of AI-powered bots that cover various timeframes and risk levels, allowing investors to match approaches to their own outlook without needing to build systems from scratch. It serves as one more data point alongside traditional analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ALB, SQM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ALB in -0.89% downward trend, sliding for three consecutive days on November 03, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALB declined for three days, in 264 of 318 cases, the price declined further within the following month. The odds of a continued downward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALB as a result. In 64 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Aroon Indicator for ALB entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALB's RSI Oscillator exited the oversold zone, 26 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for ALB just turned positive on October 23, 2026. Looking at past instances where ALB's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.

Following a +0.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALB advanced for three days, in 246 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ALB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.329) is normal, around the industry mean (2.487). P/E Ratio (192.681) is within average values for comparable stocks, (-18.741). Projected Growth (PEG Ratio) (0.959) is also within normal values, averaging (1.548). Dividend Yield (0.018) settles around the average of (0.040) among similar stocks. P/S Ratio (2.352) is also within normal values, averaging (48.960).

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.83B. The market cap for tickers in the group ranges from 50 to 235.81B. LIN holds the highest valuation in this group at 235.81B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -7%. SNES experienced the highest price growth at 48%, while YMAT experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -0%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 54
Price Growth Rating: 53
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -1 (-100 ... +100)